Interim Buprenorphine: Leveraging Medication + Technology to Bridge Delays in Treatment Access
NCT02360007
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Opioid-related Disorders
Interventions
DRUG:
Interim Buprenorphine Treatment (IBT)
Sponsor
University of Vermont Medical Center